Flavonoids as drugs at the small intestinal level

Current Opinion in Pharmacology

Volumn 13, Issue 6, 2013, Pages 864-868

  Wenzel, Uwe ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACARBOSE; ALPHA GLUCOSIDASE; AMYLASE; ASTRAGALIN; BREAST CANCER RESISTANCE PROTEIN; CHRYSIN; CYTOSTATIC AGENT; FISETIN; FLAVANOL DERIVATIVE; FLAVANONE DERIVATIVE; FLAVONE DERIVATIVE; FLAVONOID; FLAVONOID GLYCOSIDE; FLAVONOL DERIVATIVE; GLUCOSE TRANSPORTER; GLUCOSE TRANSPORTER 2; ISOFLAVONE DERIVATIVE; LUTEOLIN; MULBERRY EXTRACT; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 2; MYRICETIN; NARINGENIN; PELARGONIDIN; PHLORIZIN; QUERCETIN; RUTOSIDE; SODIUM GLUCOSE COTRANSPORTER 1; TOPOTECAN; UNINDEXED DRUG;

APICAL MEMBRANE; ARTICLE; CANCER CELL; DIABETES MELLITUS; DRUG BIOAVAILABILITY; DRUG POTENCY; DRUG PROTEIN BINDING; DRUG STRUCTURE; ENZYME INHIBITION; FLATULENCE; HUMAN; HYPERGLYCEMIA; IC 50; INTESTINE CELL; METEORISM; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SMALL INTESTINE;

ANIMALS; BIOLOGICAL TRANSPORT; DIABETES MELLITUS, TYPE 2; FLAVONOIDS; HUMANS; INTESTINE, SMALL; MEMBRANE TRANSPORT PROTEINS; NEOPLASMS;

EID: 84888202598     PISSN: 14714892     EISSN: 14714973     Source Type: Journal    
DOI: 10.1016/j.coph.2013.08.015     Document Type: Review

References (45)

1. P.G. Pietta Flavonoids as antioxidants J Nat Prod 63 2000 1035 1042
2. M. Marín, and S. Máñez Recent trends in the pharmacological activity of isoprenyl phenolics Curr Med Chem 20 2013 272 279
3. C.C. Wang, and J.E. Reusch Diabetes and cardiovascular disease: changing the focus from glycemic control to improving long-term survival Am J Cardiol 110 2012 58B 68B
4. I. Vucenik, and J.P. Stains Obesity and cancer risk: evidence, mechanisms, and recommendations Ann N Y Acad Sci 1271 2012 37 43
5. A. Matsuda, and R. Machii Worldwide relative burden of cancer death in 2008 extrapolated from the WHO mortality database Jpn J Clin Oncol 43 2013 102
6. C. Martin, Y. Zhang, C. Tonelli, and K. Petroni Plants, diet, and health Annu Rev Plant Biol 64 2013 19 46
7. L.H. Cazarolli, L. Zanatta, E.H. Alberton, M.S. Figueiredo, P. Folador, R.G. Damazio, M.G. Pizzolatti, and F.R. Silva Flavonoids: cellular and molecular mechanism of action in glucose homeostasis Mini Rev Med Chem 8 2008 1032 1038
8. Y. Li, and J.W. Paxton The effects of flavonoids on the ABC transporters: consequences for the pharmacokinetics of substrate drugs Expert Opin Drug Metab Toxicol 9 2013 267 285
9. N.C. Veitch, and R.J. Grayer Flavonoids and their glycosides, including anthocyanins Nat Prod Rep 28 2011 1626 1695
10. E. Standl, and O. Schnell Alpha-glucosidase inhibitors 2012 - cardiovascular considerations and trial evaluation Diab Vasc Dis Res 9 2012 163 169
11. G.N. Kim, Y.I. Kwon, and H.D. Jang Mulberry leaf extract reduces postprandial hyperglycemia with few side effects by inhibiting α-glucosidase in normal rats J Med Food 14 2011 712 717
12. K. Tadera, Y. Minami, K. Takamatsu, and T. Matsuoka Inhibition of alpha-glucosidase and alpha-amylase by flavonoids J Nutr Sci Vitaminol 52 2006 149 153
13. J.S. Kim, C.S. Kwon, and K.H. Son Inhibition of alpha-glucosidase and amylase by luteolin, a flavonoid Biosci Biotechnol Biochem 64 2000 2458 2461
14. G. Williamson Possible effects of dietary polyphenols on sugar absorption and digestion Mol Nutr Food Res 57 2013 48 57
15. P.C. Hollman, J.H. De Vries, S.D. Van Leeuwen, M.J. Mengelers, and M.B. Katan Absorption of dietary quercetin glycosides and quercetin in healthy ileostomy volunteers Am J Clin Nutr 62 1995 1276 1282
16. P.C. Hollman, J.M. van Trijp, M.N. Buysman, M.S. van der Gaag, M.J. Mengelers, J.H. de Vries, and M.B. Katan Relative bioavailability of the antioxidant flavonoid quercetin from various foods in man FEBS Lett 418 1997 152 156 (Pubitemid 27514436)
17. C.S. Hummel, C. Lu, J. Liu, C. Ghezzi, B.A. Hirayama, D.D. Loo, V. Kepe, J.R. Barrio, and E.M. Wright Structural selectivity of human SGLT inhibitors Am J Physiol Cell Physiol 302 2012 C373 C382
18. +/glucose transporter when expressed in Xenopus laevis oocytes, but effectively inhibit electrogenic glucose uptake J Pharmacol Exp Ther 322 2007 829 835 (Pubitemid 47105799)
19. G.L. Kellett, E. Brot-Laroche, O.J. Mace, and A. Leturque Sugar absorption in the intestine: the role of GLUT2 Annu Rev Nutr 28 2008 35 54
20. A. Ait-Omar, M. Monteiro-Sepulveda, C. Poitou, M. Le Gall, A. Cotillard, J. Gilet, K. Garbin, A. Houllier, and D. Château GLUT2 accumulation in enterocyte apical and intracellular membranes: a study in morbidly obese human subjects and ob/ob and high fat-fed mice Diabetes 60 2011 2598 2607
21. O. Kwon, P. Eck, S. Chen, C.P. Corpe, J.H. Lee, M. Kruhlak, and M. Levine Inhibition of the intestinal glucose transporter GLUT2 by flavonoids FASEB J 21 2007 366 377 (Pubitemid 46213484)
22. N. Suksomboon, N. Poolsup, S. Boonkaew, and C.C. Suthisisang Meta-analysis of the effect of herbal supplement on glycemic control in type 2 diabetes J Ethnopharmacol 137 2011 1328 1333
23. T. Goto, M. Horita, H. Nagai, A. Nagatomo, N. Nishida, Y. Matsuura, and S. Nagaoka Tiliroside, a glycosidic flavonoid, inhibits carbohydrate digestion and glucose absorption in the gastrointestinal tract Mol Nutr Food Res 56 2012 435 445
24. +-glucose cotransporter by naringenin Int J Biochem Cell Biol 38 2006 985 995 (Pubitemid 43363427)
25. U.J. Jung, M.K. Lee, K.S. Jeong, and M.S. Choi The hypoglycemic effects of hesperidin and naringin are partly mediated by hepatic glucose-regulating enzymes in C57BL/KsJ-db/db mice J Nutr 134 2004 2499 2503 (Pubitemid 39315245)
26. S.E. Rasmussen, and V.M. Breinholt Non-nutritive bioactive food constituents of plants: bioavailability of flavonoids Int J Vitam Nutr Res 73 2003 101 111 (Pubitemid 36427777)
27. R. Tsuchihashi, S. Sakamoto, M. Kodera, T. Nohara, and J. Kinjo Microbial metabolism of soy isoflavones by human intestinal bacterial strains J Nat Med 62 2008 456 460
28. T.L. Farrell, M. Gomez-Juaristi, L. Poquet, K. Redeuil, K. Nagy, M. Renouf, and G. Williamson Absorption of dimethoxycinnamic acid derivatives in vitro and pharmacokinetic profile in human plasma following coffee consumption Mol Nutr Food Res 56 2012 1413 1423
29. Y. Xie, X. Zeng, G. Li, Z. Cai, N. Ding, and G. Ji Assessment of intestinal absorption of total flavones of Hippophae rhamnoides L. in rat using in situ absorption models Drug Dev Ind Pharm 36 2010 787 794
30. C. Laurent, C. Feidt, N. Grova, D. Mpassi, E. Lichtfouse, F. Laurent, and G. Rychen Portal absorption of 14C after ingestion of spiked milk with 14C-phenanthrene, 14C-benzo[a]pyrene or 14C-TCDD in growing pigs Chemosphere 48 2002 843 848 (Pubitemid 34857480)
31. H. Zahreddine, and K.L. Borden Mechanisms and insights into drug resistance in cancer Front Pharmacol 4 2013 28
32. Y. Li, J. Lu, and J.W. Paxton The role of ABC and SLC transporters in the pharmacokinetics of dietary and herbal phytochemicals and their interactions with xenobiotics Curr Drug Metab 13 2012 624 639
33. Wahajuddin, I. Taneja, S. Arora, K.S. Raju, and N. Siddiqui Disposition of pharmacologically active dietary isoflavones in biological systems Curr Drug Metab 14 2013 369 380
34. L.M. Chan, S. Lowes, and B.H. Hirst The ABCs of drug transport in intestine and liver: efflux proteins limiting drug absorption and bioavailability Eur J Pharm Sci 21 2004 25 51 (Pubitemid 38050202)
35. T. Murakami, and M. Takano Intestinal efflux transporters and drug absorption Expert Opin Drug Metab Toxicol 4 2008 923 939
36. P. Matsson, J.M. Pedersen, U. Norinder, C.A. Bergström, and P. Artursson Identification of novel specific and general inhibitors of the three major human ATP-binding cassette transporters P-gp, BCRP and MRP2 among registered drugs Pharm Res 26 2009 1816 1831
37. M. Falasca, and K.J. Linton Investigational ABC transporter inhibitors Expert Opin Investig Drugs 21 2012 657 666
38. Y. Su, S.H. Lee, and P.J. Sinko Inhibition of efflux transporter ABCG2/BCRP does not restore mitoxantrone sensitivity in irinotecan-selected human leukemia CPT-K5 cells: evidence for multifactorial multidrug resistance Eur J Pharm Sci 29 2006 102 110 (Pubitemid 44332882)
39. S. Shukla, C.P. Wu, and S.V. Ambudkar Development of inhibitors of ATP-binding cassette drug transporters: present status and challenges Expert Opin Drug Metab Toxicol 4 2008 205 223 (Pubitemid 351308418)
40. A.I. Alvarez, R. Real, M. Pérez, G. Mendoza, J.G. Prieto, and G. Merino Modulation of the activity of ABC transporters (P-glycoprotein, MRP2, BCRP) by flavonoids and drug response J Pharm Sci 99 2009 598 617
41. K. Katayama, K. Masuyama, S. Yoshioka, H. Hasegawa, J. Mitsuhashi, and Y. Sugimoto Flavonoids inhibit breast cancer resistance protein-mediated drug resistance: transporter specificity and structure-activity relationship Cancer Chemother Pharmacol 60 2007 789 797 (Pubitemid 47389385)
42. W. Brand, P.A. van der Wel, M.J. Rein, D. Barron, G. Williamson, P.J. van Bladeren, and I.M. Rietjens Metabolism and transport of the citrus flavonoid hesperetin in Caco-2 cell monolayers Drug Metab Dispos 36 2008 1794 1802
43. R. Cermak, and S. Wolffram The potential of flavonoids to influence drug metabolism and pharmacokinetics by local gastrointestinal mechanisms Curr Drug Metab 7 2006 729 744 (Pubitemid 44509679)
44. M. Schumacher, A. Hautzinger, A. Rossmann, S. Holzhauser, D. Popovic, A. Hertrampf, S. Kuntz, M. Boll, and U. Wenzel Chrysin blocks topotecan-induced apoptosis in Caco-2 cells in spite of inhibition of ABC-transporters Biochem Pharmacol 80 2010 471 479
45. K.M. Tainton, M.J. Smyth, J.T. Jackson, J.E. Tanner, L. Cerruti, S.M. Jane, P.K. Darcy, and R.W. Johnstone Mutational analysis of P-glycoprotein: suppression of caspase activation in the absence of ATP-dependent drug efflux Cell Death Differ 11 2004 1028 1037 (Pubitemid 39232362)